BlackRock’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.4M Sell
2,748,077
-153,948
-5% -$694K ﹤0.01% 3247
2025
Q1
$12.9M Sell
2,902,025
-96,447
-3% -$427K ﹤0.01% 3153
2024
Q4
$23.5M Sell
2,998,472
-26,763
-0.9% -$210K ﹤0.01% 2900
2024
Q3
$39.8M Buy
3,025,235
+86,517
+3% +$1.14M ﹤0.01% 2585
2024
Q2
$35.5M Buy
2,938,718
+81,461
+3% +$984K ﹤0.01% 2582
2024
Q1
$46.5M Sell
2,857,257
-59,823
-2% -$973K ﹤0.01% 2428
2023
Q4
$19.9M Buy
2,917,080
+443,724
+18% +$3.03M ﹤0.01% 2961
2023
Q3
$13.5M Sell
2,473,356
-58,423
-2% -$318K ﹤0.01% 3102
2023
Q2
$17.2M Buy
2,531,779
+170,686
+7% +$1.16M ﹤0.01% 3061
2023
Q1
$11.8M Sell
2,361,093
-217,683
-8% -$1.09M ﹤0.01% 3160
2022
Q4
$12.6M Sell
2,578,776
-318,618
-11% -$1.55M ﹤0.01% 3222
2022
Q3
$41.8M Sell
2,897,394
-78,827
-3% -$1.14M ﹤0.01% 2555
2022
Q2
$45M Buy
2,976,221
+31,127
+1% +$471K ﹤0.01% 2529
2022
Q1
$35M Buy
2,945,094
+177,734
+6% +$2.11M ﹤0.01% 2751
2021
Q4
$44.9M Buy
2,767,360
+30,500
+1% +$494K ﹤0.01% 2690
2021
Q3
$78.1M Buy
2,736,860
+33,169
+1% +$947K ﹤0.01% 2341
2021
Q2
$91.4M Buy
2,703,691
+178,915
+7% +$6.05M ﹤0.01% 2291
2021
Q1
$76.4M Buy
2,524,776
+106,196
+4% +$3.21M ﹤0.01% 2321
2020
Q4
$120M Buy
2,418,580
+72,823
+3% +$3.61M ﹤0.01% 1951
2020
Q3
$90.1M Buy
2,345,757
+33,965
+1% +$1.3M ﹤0.01% 1918
2020
Q2
$99.9M Buy
2,311,792
+331,723
+17% +$14.3M ﹤0.01% 1832
2020
Q1
$51.7M Sell
1,980,069
-33,022
-2% -$862K ﹤0.01% 2011
2019
Q4
$62.9M Buy
2,013,091
+688,524
+52% +$21.5M ﹤0.01% 2206
2019
Q3
$34.5M Buy
1,324,567
+170,736
+15% +$4.45M ﹤0.01% 2486
2019
Q2
$26.4M Buy
1,153,831
+784,672
+213% +$17.9M ﹤0.01% 2666
2019
Q1
$9.68M Buy
369,159
+27,328
+8% +$716K ﹤0.01% 3109
2018
Q4
$6.95M Buy
341,831
+326,831
+2,179% +$6.65M ﹤0.01% 3251
2018
Q3
$398K Buy
+15,000
New +$398K ﹤0.01% 4108